Indication
Ewing's sarcoma
Ewing's sarcoma is an aggressive malignant neoplasm composed of small round blue cells that predominantly arises within the bones—commonly the pelvis, femur, and other long bones—or less frequently in adjacent soft tissues. Read more about Ewing's sarcoma
7 drugs 7 manufacturers
Drugs that treat it
Common Ewing's sarcoma therapies.
DACTINOMYCIN
DACTINOMYCIN
DACTINOMYCIN
DACTINOMYCIN
DACTINOMYCIN
DACTINOMYCIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEwing's sarcoma is an aggressive malignant neoplasm composed of small round blue cells that predominantly arises within the bones—commonly the pelvis, femur, and other long bones—or less frequently in adjacent soft tissues.
It most frequently affects children, adolescents, and young adults, typically manifesting with localized bone pain, swelling, and palpable soft-tissue masses.
Pathophysiologically, the disease is defined by characteristic chromosomal translocations fusing the *EWSR1* gene with an ETS family transcription factor, most commonly generating the *EWSR1::FLI1* fusion oncoprotein that drives aberrant transcription and oncogenesis.
Ewing's sarcoma is clinically notable for its high propensity for early micrometastatic and overt hematogenous spread, most frequently involving the lungs, distant bones, and bone marrow.
- cancer.gov
Ewing's sarcoma is an aggressive malignant neoplasm composed of small round blue cells that predominantly arises within the bones—commonly the pelvis, femur, and other long bones—or less frequently in adjacent soft tissues
- nih.gov
Ewing's sarcoma is an aggressive malignant neoplasm composed of small round blue cells that predominantly arises within the bones—commonly the pelvis, femur, and other long bones—or less frequently in adjacent soft tissues It most frequently affects children, adolescents, and young adults, typically manifesting with localized bone pain, swelling, and palpable soft-tissue masses
- clevelandclinic.org
Ewing's sarcoma is clinically notable for its high propensity for early micrometastatic and overt hematogenous spread, most frequently involving the lungs, distant bones, and bone marrow
Personalize your experience
Follow Ewing's sarcoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.